Mixed Market

10:34 a.m. ET Briefly, the averages are losing momentum as suspected in a mixed start. Futures initially surged on Pfizer and BioNTech SE saying early lab studies show a third dose of their Covid-19 vaccine neutralizes the omicron variant. However, the gains faded with the S&P 500 flat and the technology-heavy NASDAQ 100 feeling some…

Please login to view this content. (Register here.)